fluorouracil has been researched along with stearylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hassanzadeh, F; Khadem, M; Sadeghi, H; Varshosaz, J | 1 |
| Andalib, S; Hassanzadeh, F; Sadeghi, H; Varshosaz, J | 1 |
2 other study(ies) available for fluorouracil and stearylamine
| Article | Year |
|---|---|
Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Topics: Acetone; Amines; Antineoplastic Agents; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Delayed-Action Preparations; Disaccharides; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Fluorouracil; Galactose; Glycerides; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Nanoparticles; Oleic Acid; Particle Size; Polysorbates; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tetrazolium Salts; Thiazoles; Toxicity Tests | 2012 |
Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers.
Topics: Amines; Antineoplastic Agents; Cell Proliferation; Cell Survival; Chemistry Techniques, Synthetic; Cholesterol; Drug Carriers; Fluorouracil; HT29 Cells; Humans; Nanostructures; Receptors, LDL; Structure-Activity Relationship; Tretinoin | 2012 |